Sotera Health Company (NASDAQ:SHC) Shares Bought by Principal Financial Group Inc.

Principal Financial Group Inc. increased its stake in shares of Sotera Health Company (NASDAQ:SHC) by 0.3% in the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 352,388 shares of the company’s stock after purchasing an additional 1,037 shares during the quarter. Principal Financial Group Inc. owned 0.12% of Sotera Health worth $4,109,000 as of its most recent SEC filing.

Other large investors have also recently bought and sold shares of the company. Teacher Retirement System of Texas acquired a new position in shares of Sotera Health in the 1st quarter valued at about $266,000. New York State Teachers Retirement System increased its holdings in shares of Sotera Health by 1.9% in the 1st quarter. New York State Teachers Retirement System now owns 59,273 shares of the company’s stock valued at $691,000 after acquiring an additional 1,100 shares during the last quarter. Farther Finance Advisors LLC boosted its position in Sotera Health by 4,881.9% during the 1st quarter. Farther Finance Advisors LLC now owns 6,327 shares of the company’s stock valued at $70,000 after purchasing an additional 6,200 shares during the period. GAMMA Investing LLC boosted its position in Sotera Health by 816.3% during the 1st quarter. GAMMA Investing LLC now owns 37,650 shares of the company’s stock valued at $439,000 after purchasing an additional 33,541 shares during the period. Finally, California State Teachers Retirement System boosted its position in Sotera Health by 8.0% during the 4th quarter. California State Teachers Retirement System now owns 145,411 shares of the company’s stock worth $1,989,000 after acquiring an additional 10,778 shares during the period. Hedge funds and other institutional investors own 91.03% of the company’s stock.

Sotera Health Price Performance

SHC opened at $11.23 on Friday. The company has a fifty day moving average price of $11.93 and a 200-day moving average price of $12.21. The firm has a market capitalization of $3.19 billion, a P/E ratio of 140.39 and a beta of 1.81. The company has a debt-to-equity ratio of 5.55, a current ratio of 2.46 and a quick ratio of 2.19. Sotera Health Company has a one year low of $9.53 and a one year high of $17.08.

Sotera Health (NASDAQ:SHC) last issued its quarterly earnings data on Thursday, May 1st. The company reported $0.14 EPS for the quarter, beating the consensus estimate of $0.12 by $0.02. Sotera Health had a net margin of 2.24% and a return on equity of 41.08%. The firm had revenue of $254.52 million during the quarter, compared to the consensus estimate of $245.56 million. During the same period in the prior year, the firm posted $0.13 earnings per share. The company’s quarterly revenue was up 2.6% compared to the same quarter last year. Equities research analysts expect that Sotera Health Company will post 0.61 earnings per share for the current fiscal year.

Analyst Ratings Changes

Several research analysts recently weighed in on SHC shares. Piper Sandler dropped their price target on Sotera Health from $15.00 to $13.00 and set a “neutral” rating on the stock in a research report on Wednesday, April 23rd. Wall Street Zen raised Sotera Health from a “hold” rating to a “buy” rating in a report on Saturday, June 28th. Barclays lowered their target price on Sotera Health from $15.00 to $13.00 and set an “overweight” rating for the company in a research note on Tuesday, June 24th. Finally, The Goldman Sachs Group upgraded Sotera Health from a “neutral” rating to a “buy” rating and lifted their target price for the stock from $14.00 to $17.00 in a report on Monday, May 5th. One investment analyst has rated the stock with a hold rating and five have assigned a buy rating to the stock. According to data from MarketBeat.com, Sotera Health presently has an average rating of “Moderate Buy” and an average price target of $16.00.

Sotera Health Company Profile

Sotera Health Company engages in the provision of sterilization, lab testing, and advisory services in the United States and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. It provides mission-critical end-to-end sterilization services, including gamma and electron beam irradiation, and ethylene oxide processing, as well as designs, installs, and maintains gamma irradiation systems.